Aphakic cystoid macular edema. Longterm clinical observations

Area of Science:

• Ophthalmology
• Surgical Outcomes
• Medical Device Technology

Background:

• Clinically significant cystoid macular edema (CME) is a growing concern after cataract surgery, particularly with intraocular lens (IOL) use.
• Evaluating the incidence of CME across different surgical techniques is crucial for patient safety and visual outcomes.

Purpose of the Study:

• To compare the incidence of CME following three distinct cataract surgery methods.
• To identify factors contributing to CME and assess visual outcomes in each surgical group.

Main Methods:

• Retrospective analysis of 1808 cataract cases.
• Categorization into three groups: intracapsular cataract extraction (ICCE) without IOL, ICCE with iris-supported IOL, and extracapsular cataract extraction (ECCE) with posterior chamber IOL.
• Comparison of CME incidence and visual outcomes across groups.

Main Results:

• CME incidence was 2% for ICCE without IOL, 9.9% for ICCE with iris-supported IOL, and 1.2% for ECCE with posterior chamber IOL.
• The ECCE with posterior chamber IOL group demonstrated the lowest CME incidence.
• Visual outcomes were reviewed for all groups.

Conclusions:

• Extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens (IOL) implantation significantly reduces the risk of cystoid macular edema (CME) compared to older methods.
• The ECCE-posterior chamber IOL procedure appears to mitigate many complications associated with intracapsular cataract extraction (ICCE) and iris-supported IOLs.
• Long-term follow-up is essential to fully ascertain the safety profile of the ECCE-posterior chamber IOL technique.